Physician profile
William Harris
NPI 1588662068
$3,184.11
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,166 · 2020: $1,327 · 2021: $264 · 2022: $169 · 2023: $153 · 2024: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $743.98 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $352.73 | 2019-2021 | |
| Abbvie INC. | $226.14 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $221.47 | 2019-2021 | |
| Pfizer INC. | $197.79 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $175.66 | 2019-2024 | Rexulti |
| Amgen INC. | $173.75 | 2019-2021 | |
| Novo Nordisk INC | $173.52 | 2019-2020 | |
| Abbott Laboratories | $157.83 | 2022-2023 | Freestyle Libre 3 |
| Genentech USA, INC. | $150.00 | 2022 | |
| Lilly USA, LLC | $139.54 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $103.98 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $76.99 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $58.78 | 2019-2020 | |
| Shire North American Group INC | $44.50 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $40.08 | 2019 | |
| Daiichi Sankyo INC. | $35.93 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $30.34 | 2019-2021 | |
| Bausch Health US, LLC | $20.95 | 2019 | |
| Alfasigma USA, INC. | $19.26 | 2020 | |
| Lupin INC. | $14.64 | 2019 | |
| Exact Sciences Corporation | $13.68 | 2023 | Cologuard Collection Kit |
| Eisai INC. | $12.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.